In our study, HAfT25 was overexpressed by 51-fold (Fig 1) after 90-day treatment with AFB1 prior to development of hepatocellular carcinomas, but Myc transcript expression was not increased, suggesting HAfT25 may engage other pathways involved in transformation in the preneoplastic rat liver. This evidence concerns the gene MYC and hepatocellular carcinoma.